Search
for
Sort by
Research 31–60 of 1000+
- The Glucocorticoid Resistance Syndrome. Two Cases of a Novel Pathogenic Variant in the Glucocorticoid Receptor Gene
- Medical Treatment of Hirsutism in Women
- Congenital Adrenal Hyperplasia
- Hormone therapy in acne
- GRowing an Epidermal Tumor
- An X-traordinary stroke
- The Polycystic Ovary Syndrome and Acne
- Genetics and Pathophysiology of Congenital Adrenal Hyperplasia
- Dermatological drugs, topical agents, and cosmetics
- PHARMACOLOGICAL BASIS FOR CLINICAL USE OF ANTIANDROGENS
- Pharmacokinetics and Bioconversion of Dehydroepiandrosterone after Application of Dexamethasone in Women with Polycystic Ovary Syndrome
- A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity
- Glucocorticoid Receptor Mutants Demonstrate Increased Motility Inside the Nucleus of Living Cells: Time of Fluorescence Recovery After Photobleaching (FRAP) Is an Integrated Measure of Receptor Function
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- Cedrol mitigates hepatic lipid accumulation and adipocyte hypertrophy induced by corticosteroids through the inhibition of glucocorticoid receptor activity
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Skin and glucocorticoids: effects of local skin glucocorticoid impairment on skin homeostasis
- Polymeric micelle mediated follicular delivery of spironolactone: Targeting the mineralocorticoid receptor to prevent glucocorticoid-induced activation and delayed cutaneous wound healing
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- 258 11β-hydroxysteroid dehydrogenase type 1 inhibition attenuates the adverse effects of glucocorticoids on dermal papilla cells
- Androgen excess: a hallmark of polycystic ovary syndrome
- Unravelling the link between insulin resistance and androgen excess
- How should postmenopausal androgen excess be evaluated?
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Treatment guidelines in adult women
- Glucocorticoid Resistance Syndrome in 2 Patients With Diverse Genotype
- AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cells
- Glucocorticoid corticosteroids for Duchenne muscular dystrophy
- Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering